| LXRX Stock | | | USD 0.80 0.02 2.44% |
Lexicon Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Lexicon Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lexicon Pharmaceuticals is a good investment. Please check the relationship between Lexicon Pharmaceuticals Begin Period Cash Flow and its Net Income accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexicon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Lexicon Stock please use our
How to Invest in Lexicon Pharmaceuticals guide.
Begin Period Cash Flow vs Net Income
Begin Period Cash Flow vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Lexicon Pharmaceuticals Begin Period Cash Flow account and
Net Income. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Lexicon Pharmaceuticals' Begin Period Cash Flow and Net Income is -0.03. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Net Income in the same time period over historical financial statements of Lexicon Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Lexicon Pharmaceuticals' Begin Period Cash Flow and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Lexicon Pharmaceuticals are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Begin Period Cash Flow i.e., Lexicon Pharmaceuticals' Begin Period Cash Flow and Net Income go up and down completely randomly.
Correlation Coefficient | -0.03 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Lexicon Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Lexicon Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most indicators from Lexicon Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lexicon Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexicon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Lexicon Stock please use our
How to Invest in Lexicon Pharmaceuticals guide.At this time, Lexicon Pharmaceuticals'
Selling General Administrative is fairly stable compared to the past year.
Issuance Of Capital Stock is likely to rise to about 145.7
M in 2024, whereas
Enterprise Value Over EBITDA is likely to drop
(2.71) in 2024.
Lexicon Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Lexicon Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lexicon Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Lexicon Stock Analysis
When running Lexicon Pharmaceuticals' price analysis, check to
measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.